New Cancer Treatment Jab Approved for NHS Rollout

This chapter covers the approval and imminent rollout of a new cancer treatment jab, nivolumab, which promises a more convenient administration method. Highlighting high patient satisfaction, the jab will be available at no extra cost to the NHS, coinciding with the UK's preparation of a national cancer plan to improve care capacity.